Covid-19, war, high inflation may decelerate global growth: World Bank
Global growth may decelerate sharply in 2023 to its third weakest pace in nearly three decades, according to World Bank’s Global Economic Prospects.
Climate
Pharma
Drugs
Medical
Pharma
Every 4.4 seconds, a child or youth died in 2021: WHO
A child or youth died every 4.4 seconds in 2021 and about five million children died before their fifth birthday, due to labor.
Drugs
Pharma
AstraZeneca to acquire US-based CinCor for $1.8 billion
AstraZeneca, a British-Swedish global pharmaceutical and biotechnology company, will buy CinCor Pharma, Inc., for $1.8 billion, according to a statement.
Health
Medical
Pharma
World shortage of health care workers to rise to 10m: WEF
A global shortage of healthcare workers may rise to 10 million by 2030, affecting access to care, increasing inequities and treatment of mental.
Health
Medical
Pharma
Your age may say a lot about your cognitive health
A new artificial intelligence-driven model can analyse magnetic resonance imaging of brain scans to accurately capture cognitive decline linked to neurodegenerative diseases such.
Drugs
Pharma
Combined dish-and-chip technology to open ways to treat kidney disorder
US scientists have combined two technologies to show the effect of glucose in polycystic kidney disorder, a life-threatening genetic disorder, according to a.
Drugs
Pharma
Moderna in $35 million licensing deal with CytomX
Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.
Drugs
Pharma
FDA gives accelerated approval for Alzheimer’s drug
The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.
Health
Medical
Pharma
Can harvest waste LED energy using human body as antenna: Scientists
US scientists have developed a low-cost way to harvest waste energy from visible light communication by using the human body as an antenna.
Drugs
Pharma
Dabur India forecasts low to single-digit Q3 revenue growth
Dabur India, an ayurvedic and natural healthcare company, forecasts a low to mid-single-digit revenue growth for the third quarter ending December 31 due.